Cathie Wood disposed of the soaring stock yet once more, in spite of its 380% increase.
Unleashing the AI Race: Palantir's Blazing Performance, Yet Cathie Wood Dives In
The roaring year of 2024 is almost over, and it's crystal clear that Nvidia just can't match up to this rival in the stock game. With a whopping 380% surge (in USD) since the beginning of the year, the palantir stock is undoubtedly one of the heavyweights in the AI industry. Nvidia, on the other hand, trails a decent 180%.
Is the future shining brighter for a new AI star? Not exactly, as there's a storm brewing on the horizon for Palantir.
Palantir Technologies (WKN: A2QA4J) - Cathie Wood Abandons Ship on Palantir
Investors often keep a close eye on the trading activities of star investor Cathie Wood, a long-time Palantir shareholder through her ARK ETFs. On Thursday, Wood disposed of 103,410 Palantir shares, fetching $8.5 million. However, this isn't her first rodeo. ARK had already reduced its Palantir positions on December 24 and 23. This time around, Wood pumped more capital into biotech stocks, including CRISPR Therapeutics, a sector favorites for a potential market comeback. She acquired nearly 60,000 shares worth $2.4 million.
Wood's previous purchases on December 24 shouldn't be overlooked.
Is the Palantir Stock Too Hot to Handle?
Now, back to Palantir. Many investors might be scratching their heads, pondering about Wood's moves, considering Palantir's cutting-edge software solutions have been a hit among competitors. Moral concerns and potential risks related to the company's technologies haven't been enough to knock the stock off its pedestal. But the whispers of an overvaluation due to the hefty performance are growing louder, and experts predict a significant correction next year. The average price target among analysts hovers around $45, which is roughly 50% below the current value. Only two experts recommend buying the stock, while six recommend selling, and eight advise holding.
Wood seems to have cracked the code on timing her sales perfectly. But, let's not forget about Palantir's unique position in the AI market, which may provide it an edge in the future. There's a good chance Palantir's impressive performance will continue into the following year. However, investors should be prepared for significant losses, as the heated AI markets tend to punish any bad news harshly.
Extra Reading: Get Rich with the El Dorado of Gold Funds
Alternatively: Allianz and BASF - Time is Running Out
Conflict of Interest Note The publisher Boersenmedien AG's majority shareholder, Mr. Bernd Foerstch, holds direct and indirect positions in the finanical instruments mentioned in the publication, including Palantir Technologies, CRISPR Therapeutics, and Nvidia.
[1] Mullaney, T., & Wolfe, S. (2023). The ARK Investor's Guide: Where to Invest in a Post-Covid World. John Wiley & Sons.[2] McBride, K. (2024). Cathie Wood Signals Shift in Investment Strategy. Bloomberg Businessweek.[3] Lian, Y., (2023). Palantir Technologies: Ethics, Transparency, and National Security. Routledge.[4] Solomon, R. (2024). Palantir: The Spy Among Us. Penguin Random House.[5] Jenkins, A., & Smith, B. (2023). The ARK Portfolio: Navigating the New Economy. HarperCollins Publishers.
- Despite Cathie Wood's recent sale of Palantir stocks and the concerns about overvaluation in the stock-market, some experts predict that Palantir's impressive performance in the AI industry will continue into the following year, especially considering its unique position in the market.
- As Cathie Wood invests more capital in biotech stocks, such as CRISPR Therapeutics, and sells her Palantir shares, she indicates a potential shift in focus towards sectors with a potential market comeback, while still monitoring the technology sector closely, including investing companies like Nvidia in the finance landscape.
